End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | -1.40% | +16.29% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.29% | 3.73B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Transcript : Alvotech, 2023 Earnings Call, Mar 21, 2024